Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New CEO at Cevec Pharmaceuticals

This article was originally published in Scrip

Executive Summary

Cevec Pharmaceuticals, a Germany biopharmaceutical company specialising in the development of therapeutic proteins using their proprietary human cell expression systems, has appointed Dr Rainer Lichtenberger chief executive officer. He succeeds Professor Stefan Kochanek, one of the founders of the company, who has led the company as interim CEO for almost half a year and will continue to serve as one of the advisory board members. Dr Lichtenberger has 20 years' management experience in companies such as the Merckle/ratiopharm group and Merck KGaA.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts